Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.58
-0.1600-4.28%
Post-market: 3.600.0195+0.54%19:46 EDT
Volume:1.28M
Turnover:4.59M
Market Cap:276.33M
PE:-4.16
High:3.76
Open:3.76
Low:3.50
Close:3.74
52wk High:4.60
52wk Low:1.35
Shares:77.19M
Float Shares:69.92M
Volume Ratio:1.75
T/O Rate:1.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8609
EPS(LYR):-0.5566
ROE:-72.68%
ROA:-35.10%
PB:2.75
PE(LYR):-6.43

Loading ...

Here's Why We're Watching Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Situation

Simply Wall St.
·
Yesterday

Eledon Pharmaceuticals Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Jul 21

Natera Partners with Eledon to Supply Prospera Monitoring for Planned Phase 3 Kidney Transplant Trial

Reuters
·
Jun 25

Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial

THOMSON REUTERS
·
Jun 25

Natera - Eledon to Initiate Phase 3 Kidney Transplant Trial in Late 2026

THOMSON REUTERS
·
Jun 25

Health Rounds: Drug to prevent organ rejection after kidney transplant tops standard treatment in trial

Reuters
·
Jun 24

Guggenheim Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Jun 23

Eledon Pharmaceuticals shareholders approve increase in authorized common shares to 450 million

Reuters
·
Jun 23

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN) and MoonLake Immunotherapeutics (MLTX)

TIPRANKS
·
Jun 23

Eledon Says Mid-Stage Data Shows Tegoprubart Offers Higher Kidney Function, Improved Outcomes Compared with Tacrolimus

MT Newswires Live
·
Jun 22

Eledon posts American Transplant Congress presentation on tegoprubart kidney transplant data update

Reuters
·
Jun 22

Eledon says Phase 2 BESTOW extension shows higher kidney function with tegoprubart vs tacrolimus at 18 months

Reuters
·
Jun 22

Eledon Presents Long-Term Extension Phase 2 Bestow Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes With Tegoprubart Compared With Tacrolimus

THOMSON REUTERS
·
Jun 22

Noble Financial Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Jun 11

Eledon Pharmaceuticals announces updated results from tegoprubart trial

TIPRANKS
·
Jun 08

Eledon Announces Updated Data From Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients With Type 1 Diabetes (T1d) at Uchicago Medicine

THOMSON REUTERS
·
Jun 08

Eledon says updated tegoprubart islet transplant trial data to be presented at ADA 2026 sessions

Reuters
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 22

Eledon presents new long-term Phase 2 BESTOW kidney transplant data for tegoprubart at ATC

Reuters
·
May 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 18